Digest Network Come funziona
Network
/
Società
So
Non verificato

Sonoma Biotherapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

10 comunicati stampa

Guarda tutti i comunicati
13/07/2026
Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
17/11/2025
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
30/10/2025
Biotecnologia
Farmaceutica
Salute
Eventi
Fiere
Sonoma Biotherapeutics Announces Upcoming Poster Presentation at the 10th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA)
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
29/10/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Sonoma Biotherapeutics Announces Positive Interim Safety and Efficacy Data from Phase 1 REGULATE-RA Study of SBT-77-7101 in Refractory Rheumatoid Arthritis
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
14/10/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Eventi
Sonoma Biotherapeutics Announces Upcoming Late-Breaking Oral and Poster Presentations at the 2025 American College of Rheumatology (ACR) Convergence
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
06/10/2025
Sonoma Biotherapeutics Congratulates Fred Ramsdell, PhD, Co-Founder and Scientific Advisory Board Chair, on Receiving the 2025 Nobel Prize in Physiology or Medicine...
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
25/08/2025
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Mercato del lavoro
Sonoma Biotherapeutics Appoints Lisa Taylor Ash, JD, as Chief Legal Officer
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
05/06/2025
Eventi
Industria
Biotecnologia
Salute
Biologia
Medicina - Varie
Sonoma Biotherapeutics Announces Poster Presentation at the 2025 European Alliance of Associations for Rheumatology (EULAR) Congress
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
06/05/2025
Eventi
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
04/09/2024
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Mercato del lavoro
Sonoma Biotherapeutics Receives $45 Million Milestone Payment from Regeneron under Ongoing Collaboration
Fonte
Sonoma Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0